Icsm Adjust Testosterone Dose

---
name: icsm-adjust-testosterone-dose
description: Advises adjusting testosterone dose based on serum levels and clinical response: reduce dose if total testosterone consistently exceeds the normal range, escalate if hypogonadal symptoms persist despite sub-mid-normal levels. Triggered when a clinician reviews a patient's testosterone result and symptoms and wonders, "Do I need to change the dose or is the current dose appropriate?"
---

# Adjust testosterone dose based on serum levels and response

## STEP 1 — Gather Information
Collect a morning fasting total testosterone (tT) level, review hypogonadal symptoms (libido, morning erections, erectile function), and verify at least two separate tT measurements if initially low; then proceed to assess whether tT is consistently above the normal range.

## STEP 2 — Rule In / Rule Out
Is the patient's tT consistently measuring above the laboratory's normal reference range? If yes, move to consider dose reduction; if no, proceed to evaluate symptom control relative to tT level.

## STEP 3 — Classify or Stratify
For patients not supra-normal, assess symptoms: Do hypogonadal symptoms persist despite tT below the mid‑normal target range? If yes, flag for dose escalation; if symptoms are resolved and tT is within mid‑normal range, consider current dose adequate; if tT is low but asymptomatic, investigate alternative causes before adjusting dose.

## STEP 4 — Decide
If tT is consistently supra-normal, reduce the testosterone dose (e.g., lower injection frequency or gel amount); if symptoms persist with sub‑mid‑normal tT, escalate the dose (e.g., increase injection amount or gel quantity); if symptoms are controlled and tT is mid‑normal, maintain the current regimen.

## Clinical Guardrails / Mimics / Pitfalls
Do not adjust dose based on a single tT measurement; ensure samples are drawn fasting between 07:00–11:00; avoid escalation when symptoms may stem from depression, obesity, or medication effects; monitor hematocrit to keep <54% and prevent polycythemia; do not use dose changes to treat non‑hypogonadal conditions such as isolated fatigue or low mood without corroborative low tT.

## Concrete Clinical Example
A 48‑year‑on testosterone gel 5 g daily presents for follow‑up; morning tT is 820 ng/dL (above normal range 300–1000 ng/dL), libido and erections are improved, hematocrit is 51%. Dose is reduced to 2.5 g daily with repeat tT in 4 weeks.

**Source:** Male hypogonadism: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024), International Society for Sexual Medicine, 2025, https://doi.org/10.1093/sxmrev/qeaf036